Overview of Dr. Biran
Dr. Noa Biran is an oncologist in Hackensack, NJ and is affiliated with Hackensack Meridian Health Hackensack University Medical Center. She received her medical degree from George Washington University School of Medicine and has been in practice 9 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
As a physician in the Myeloma Division at John Theurer Cancer Center, my research is focused on high-risk multiple myeloma patients with refractory disease, many of whom have been through multiple lines of treatment. Our most promising therapy at this time is BCMA directed CAR-T cell therapy, which uses T-cells that are reengineered to target multiple myeloma. The response rate has been close to 80% in some. We are also exploring other drug therapies, including genetic approaches to treatment, and starting to move these treatment strategies to earlier in the patient’s therapy in the hopes of generating a longer remission.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2011 - 2014
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2008 - 2011
George Washington University School of Medicine and Health SciencesClass of 2008
Certifications & Licensure
NY State Medical License 2009 - 2026
NJ State Medical License 2014 - 2025
PA State Medical License 2023 - 2024
Clinical Trials
Publications & Presentations
PubMed
Localized Recurrence of Multiple Myeloma in the Lacrimal Gland.
Lisa R Koenig, Noa Biran, Jasmine H Francis, David H Abramson> ;Ophthalmic Plastic and Reconstructive Surgery. 2023 Jun 16- 1 citations
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
Gary J Schiller, Brea C Lipe, Nizar J Bahlis, Sascha A Tuchman, William I Bensinger, Heather J Sutherland, Suzanne Lentzsch, Muhamed Baljevic, Darrell White, Rami Kotb...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Sep 1 Interaction between age and gender on survival outcomes in extramedullary multiple myeloma over the past two decades.
Ayrton I Bangolo, Pierre Fwelo, Chinmay Trivedi, Sowmya Sagireddy, Hamed Aljanaahi, Auda Auda, Maryama Mohamed, Sonia Onyeka, Miriam Fisher, Jyoti Thapa, Erwin J Tabuc...> ;World Journal of Clinical Oncology. 2023 Apr 24- Join now to see all
Journal Articles
Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational Study
Noa Biran, Andrew Ip, Ronaldo Collo Go, The Lancet Rheumatology
Abstracts/Posters
Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...
Noa Biran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019Building a National CML Registry
Noa Biran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 Patients
Noa Biran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019- Join now to see all
Lectures
Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplan...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treat...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018- Join now to see all
Authored Content
Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020
Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020
Press Mentions
John Theurer Cancer Center Investigators Present Pioneering Research at the American Society of Hematology Annual ConferenceDecember 9th, 2021
John Theurer Cancer Center (JTCC) Researchers to Present 52 Abstracts Across Hematological Malignancies at the 2020 American Society of Hematology (ASH) Annual Meeting and ExpositionDecember 4th, 2020
Dr. Biran on Post-ASCT Consolidation in Multiple MyelomaJanuary 31st, 2020
- Join now to see all
